Telescope Innovations and Shimadzu Scientific Instruments Initiate Technology Partnership
Vancouver, British Columbia--(Newsfile Corp. - February 26, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of enabling technologies for the global pharmaceutical and chemical industries, announces that it is engaged in a technology integration partnership with Shimadzu Scientific Instruments, Inc. ("Shimadzu"). Shimadzu is a global leader in analytical instrumentation for chemistry research and development, and the partners aim to...
2024-02-26 8:00 AM EST
Telescope Innovations Strengthens Senior Management: Henry Dubina Appointed as CEO, Dr. Jason Hein as CTO, John Kirincic as CFO, Deborah Cotter as Corporate Secretary
Vancouver, British Columbia--(Newsfile Corp. - February 15, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of enabling technologies for the global pharmaceutical and chemical industries, is pleased to welcome Henry Dubina as Chairman and Chief Executive Officer and John Kirincic as Chief Financial Officer for the Company. Jason Hein will continue to lead Telescope's development services and research efforts as Chief Technology...
2024-02-15 8:00 AM EST
Mettler Toledo and Telescope Innovations Agree to Globally Distribute Telescope's Flagship Product, DirectInject-LC(TM)
Vancouver, British Columbia--(Newsfile Corp. - February 5, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of enabling technologies for the global pharmaceutical and chemical industries, announces it has signed a Distribution Agreement with METTLER TOLEDO (NYSE: MTD) for Telescope's online chemistry sampling and analysis product, the DirectInject-LC™. METTLER TOLEDO is a global leader of precision instruments and services, including...
2024-02-05 8:00 AM EST
Telescope Innovations Presents Results of First Fiscal Quarter 2024
Vancouver, British Columbia--(Newsfile Corp. - January 30, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal quarter ended November 30, 2023. The Company generated revenues of $1.50 M for a net income of $215,000 (Figure 1).
2024-01-30 8:00 AM EST
Telescope Innovations Files Game-Changing Provisional Patent to Purify Battery Materials
Vancouver, British Columbia--(Newsfile Corp. - January 23, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company") is a developer of advanced technologies and services for the global pharmaceutical and chemical industries. The Company focuses on process innovation, particularly for the production of medicinal compounds and battery materials. Telescope announces it has filed a provisional patent application (63/606,069) on a disruptive new technique to...
2024-01-23 8:00 AM EST
Telescope Innovations Reports Strong Growth in Fiscal Year 2023
Vancouver, British Columbia--(Newsfile Corp. - December 22, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal year ended August 31, 2023. The Company generated revenues of $2.82 M, representing an increase of 375% over the previous fiscal year.
2023-12-22 3:11 PM EST
Telescope Innovations Develops New IP for the Production of Battery Materials
Vancouver, British Columbia--(Newsfile Corp. - December 18, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, announces it has filed a provisional patent application (65/584,062) on the production of lithium sulfide, a key precursor for next-generation solid-state batteries. As an outcome of work with Standard Lithium Ltd., Telescope has...
2023-12-18 8:00 AM EST
Telescope Innovations and Mott Corporation Initiate Technology Partnership
Vancouver, British Columbia--(Newsfile Corp. - October 30, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies for the global pharmaceutical and chemical industries, announces that it has signed a Memorandum of Understanding ("MOU") partnership with Mott Corporation ("Mott"). Mott is a top technology-driven, precision filtration company, and the partners aim to commercialize a novel robotic sampling probe...
2023-10-30 8:00 AM EDT
Telescope Innovations Product Deployed by 13 Pharma Giants in First Year
Vancouver, British Columbia--(Newsfile Corp. - October 4, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies for the global pharmaceutical and chemical industries, is excited to announce that its flagship product for automated analysis of chemical reactions, Direct Inject Liquid Chromatography (DILCTM), is quickly being established in the market as a critical tool to support process development. One year...
2023-10-04 8:00 AM EDT
Telescope Innovations Is Granted a Canadian Patent on Chemical Synthesis Route
Vancouver, British Columbia--(Newsfile Corp. - August 28, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, has been granted a Canadian patent, through its wholly-owned subsidiary, for a scalable manufacturing process to produce pharmaceutically-relevant indole compounds. Telescope developed this process in response to globally rising...
2023-08-28 8:00 AM EDT
Telescope Announces Stock Option Grants
Vancouver, British Columbia--(Newsfile Corp. - August 3, 2023) - Telescope Innovations Corp. ("Telescope" or the "Company") (CSE: TELI), a chemical technology company, announces that it has granted a total of 800,000 incentive stock options (the "Options") to certain directors of the Company in accordance with the Company's incentive stock option plan. The Options are exercisable at a price of $0.27 until August 2, 2028, and vest in five tranches over a 12 month period with the first tranche...
2023-08-03 8:31 PM EDT
Telescope Innovations Receives Accelerator Funding to Develop Carbon-Negative Production of Battery Materials
Vancouver, British Columbia--(Newsfile Corp. - July 11, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, has been awarded $292,333 through Canada's Mining Innovation Commercialization Accelerator ("MICA") Network. Funds will support Telescope's development of carbon-negative production of lithium carbonate from continental brines....
2023-07-11 8:00 AM EDT
Telescope Innovations Delivers Continued Profitability in Fiscal Quarter 3, 2023
Vancouver, British Columbia--(Newsfile Corp. - June 29, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the third fiscal quarter ended May 31, 2023. Telescope is pleased to report solid growth in revenues since Q4, 2022 (Figure 1). The Company generated revenues of $1.01M and a net income of $67,847 in Q3,...
2023-06-29 8:00 AM EDT
Telescope Reports First Profitable Quarter: Fiscal Quarter 2, 2023
Vancouver, British Columbia--(Newsfile Corp. - April 25, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the second fiscal quarter ended February 28, 2023. Just over one year after securing facilities, assembling a team, and outfitting a research laboratory, the Company posted its third consecutive quarter...
2023-04-25 8:00 AM EDT
Telescope Reports First Fiscal Quarter 2023 Results
Vancouver, British Columbia--(Newsfile Corp. - February 8, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the first fiscal quarter ended November 30, 2022. The Company also announces its participation in investor events and technical conferences. "We are pleased to report our second consecutive quarter of...
2023-02-08 8:00 AM EST
Telescope Presents 2022 Fiscal Year Highlights and Investor Update
Vancouver, British Columbia--(Newsfile Corp. - January 23, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, provides a financial and corporate update. KEY HIGHLIGHTS Telescope generated revenues of CAD $595,398 in its first full fiscal year of operation ending August 31, 2022 A new Master Services Agreement with Aqualung Carbon Capture...
2023-01-23 8:00 AM EST
Telescope Announces Closing of $1.46 Million Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - November 10, 2022) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, is pleased to announce that it has closed a non-brokered private placement (the "Offering"). Upon closing of the Offering, the Company issued a total of 4,879,499 units ("Units") at a price of $0.30 per Unit for aggregate gross...
2022-11-10 5:05 PM EST
Telescope Announces Engagement with Natural Resources Canada to Develop Lithium Refinement Technology
Vancouver, British Columbia--(Newsfile Corp. - October 24, 2022) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, announces that it has been contracted by Natural Resources Canada ("NRCan") to help develop a critical lithium refinement technology. Over 16 months, Telescope will collaborate with NRCan to build an autonomous, self-driving...
2022-10-24 8:00 AM EDT
Second Nobel Prize Won by Telescope Innovations Advisor
Vancouver, British Columbia--(Newsfile Corp. - October 6, 2022) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced chemical technologies, announced today that K. Barry Sharpless, a member of Telescope's Scientific Advisory Board, and W.M. Keck Professor of Chemistry at Scripps Research, was awarded the 2022 Nobel Prize in Chemistry. Prof. Sharpless shares the award with Carolyn Bertozzi of Stanford and Morten Meldal of the...
2022-10-06 11:00 AM EDT
Telescope Welcomes Dr. Jeffrey Sherman as Chief Operating Officer
Vancouver, British Columbia--(Newsfile Corp. - September 6, 2022) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, is pleased to announce that Dr. Jeffrey Sherman has accepted the position of Chief Operating Officer of the Company. Jeff brings over thirty years of experience in the scientific instrument industry. He has worked with emerging...
2022-09-06 9:00 AM EDT